Mkts

Avanos Medical, Inc.

NYSE: AVNS
$0.00—
As of Dec 31, 7:00 PM ET

Key statistics

52-week range
10.8425.49
Today
Open0.00
Previous close0.00
Volume—
Valuation
Market cap1.17B
P/E ratio—
EPS (TTM)-1.61
Income & risk
Dividend / yield—
Beta-0.04
Avg volume1.30M
Discussion

AVNS News

Stories mentioning AVNS from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue182,200180,900177,800175,000167,500179,600170,400171,700
Cost of Goods Sold88,00094,90091,80082,90077,70081,60077,50076,100
Gross Profit94,20086,00086,00092,10089,80098,00092,90095,600
Operating Expenses
Research & Development5,2006,1006,0005,8005,4005,7007,2006,300
Sales General & Admin77,70078,80077,60083,50075,70079,70074,30080,900
Total Operating Expenses
Operating Income (Loss)8,9002,500100.00(74,500)10,300(418,500)12,0006,300
Interest Income200.00600.00500.00600.001,500800.00700.003,000
Interest Expense
Other Expense
Pretax Income7,6001,200(1,200)(75,900)9,700(420,500)9,5006,200
Tax Provision2,5002,500200.00900.003,100(23,500)3,6001,900
Net Income (Loss)5,100(1,300)(1,400)(76,800)6,600(397,300)4,3001,800
Earnings Per Share (Basic)0.11(0.03)(0.03)(1.66)0.14(8.64)0.090.04
Earnings Per Share (Diluted)0.11(0.03)(0.03)(1.66)0.14(8.64)0.090.04
Weighted Average Shares Outstanding (Basic)46,50046,30046,40046,30046,10046,00046,00045,900
Weighted Average Shares Outstanding (Diluted)47,50046,30046,40046,30046,80046,00046,60046,300

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About AVNS

Avanos Medical, Inc. (NYSE: AVNS) is a stock listed on the New York Stock Exchange under the ticker symbol AVNS. It last traded at $0.0000 (Dec 31, 1969, 7:00 PM ET). That gives Avanos Medical a market capitalisation of $1.2B.

Over the past 52 weeks AVNS has traded between $10.84 and $25.49.

Revenue for the quarter ended Mar 31, 2026 was $182.2M; net income $5.1M. Revenue was up 8.8% from $167.5M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$182.2M$5.1M2.8%
Dec 31, 2025$180.9M-$1.3M-0.7%
Sep 30, 2025$177.8M-$1.4M-0.8%
Jun 30, 2025$175.0M-$76.8M-43.9%

From Avanos Medical’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…